B&

Biomedicine & Pharmacotherapy

Biomedicine & Pharmacotherapy is a multidisciplinary journal that publishes full-length original research reports, reviews, preliminary communications, and letters to the editor in clinical and basic medicine and pharmacology, including areas such as cancer, nutriceutics, neurodegenerative, cardiac, and infectious diseases, with emphasis on molecular mechanisms, gene regulation, pharmacology, and the role of bacteria, viruses, and parasites in animals and humans.

Looking to publish in Biomedicine & Pharmacotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Medicine, Research & Experimental, Pharmacology & Pharmacy
Impact Factor 7.5
Quartile Q1
Open Access Type Open
ISSN 0753-3322
eISSN 1950-6007
Invitation Only No
Cost Range USD 3610 excluding taxes APC for all articles

Submission Instructions

Biomedicine & Pharmacotherapy accepts the following article types. Click on an article type to view submission instructions.

Original Research Reports

Cover Letter A cover letter is required with the submission. The cover letter must clearly articulate the study's aim and main findings, explain how the study fits the journal’s aim and scope, and emphasize the research's novelty and broader implications.
Abstract A concise, factual abstract is required. The abstract must not exceed 250 words. The abstract must be unstructured.
Manuscript The manuscript must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. The manuscript must include 1 to 7 English keywords, place acknowledgements in a separate section directly before the references, and include an AI declaration statement immediately before the references if AI tools were used in manuscript preparation.
References References must be cited as numbers in square brackets. References must be numbered in the order of appearance and include author names, source title information, year, and volume, article number, or pagination where applicable.
Figures & Tables Tables must be submitted as editable text and figures must be supplied as separate files along with the manuscript. All tables and figures must be cited in the text, numbered consecutively in order of appearance, and include captions.
Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

Review Articles

Cover Letter A cover letter is required with the submission. The cover letter must clearly state the study's aim and main findings, explain fit with the journal's scope, and emphasize novelty and broader implications.
Abstract A concise, factual abstract is required. Abstract must not exceed 250 words. The abstract is unstructured.
Manuscript The manuscript must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. Authors must provide 1 to 7 English keywords, include an AI declaration statement at the end of the manuscript before the references if AI tools were used in manuscript preparation, and upload a separate Review Proposal file that states relevance for the journal readership, describes the review's originality and timeliness, summarizes the authors' expertise and track record, and lists 3 representative related original research articles by the authors.
References References must be cited in the text using numbers in square brackets. References must be numbered in order of appearance and include author names, source title information, year, and volume, article number, or pagination where applicable, with journal names abbreviated according to LTWA.
Figures & Tables Tables must be submitted as editable text, while figures and other graphical media must be uploaded as separate files along with the manuscript. Tables must be cited in the text, numbered consecutively, and include captions, and figures must be cited in the text, numbered in sequence, submitted as separate files, and accompanied by captions explaining symbols and abbreviations.
Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

Preliminary Communications

Cover Letter A cover letter is required with the submission. The cover letter must briefly state the study’s aim and main findings, explain its fit with the journal’s scope, and emphasize its novelty and broader implications.
Abstract An abstract is required. The abstract must not exceed 250 words. The abstract must be unstructured.
Manuscript The manuscript must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. The manuscript must include 1 to 7 English keywords, an acknowledgements section before the references, and an AI declaration statement immediately before the references if AI tools were used in manuscript preparation.
References References must be cited in the text using numbers in square brackets and listed in the order of first appearance with required bibliographic details.
Figures & Tables Tables must be included as editable text and figures must be uploaded as separate files along with the manuscript. Tables must be cited, numbered consecutively, and include captions, and figures must be cited, numbered consecutively, and include captions that explain symbols and abbreviations.
Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

Letters To The Editor

Cover Letter A cover letter is required with the submission. The cover letter must briefly state the study's aim and main findings, explain fit with the journal’s scope, and emphasize novelty and broader implications.
Abstract A concise and factual abstract is required. The abstract must not exceed 250 words. The abstract must be unstructured and able to stand alone.
Manuscript The article must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. Authors must provide 1 to 7 English keywords, and if AI tools were used in manuscript preparation an AI declaration statement must be placed at the end of the manuscript before the references.
References References must be cited in the text using numbers in square brackets and numbered in the reference list in the order of first appearance.
Figures & Tables Tables must be included as editable text and figures must be supplied as separate files along with the manuscript. Tables must be numbered consecutively, cited in the text, and include captions, and figures must be numbered consecutively, cited in the text, and include captions explaining symbols and abbreviations where used.
Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

Recent Publications

Evaluation of hydrogen sulfide inhibition as an adjunct to gemcitabine and BCG therapy in non-muscle-invasive bladder cancer

Liam McFarlane, George J. Dugbartey, Patrick McLeod, Talal Shamma, Sally Major, Alp Sener

10.1016/j.biopha.2026.119983
View Publication

Lactylation as a potential epigenetic and metabolic modulator of cuproptosis in health and disease: Current evidence and hypotheses

Ziyi Zhang, Lingli Pan, Deyuan Li, Dongqiong Xiao

10.1016/j.biopha.2026.119981
View Publication

Dual targeting of cytochrome bd and bc1-aa3 terminal oxidases eradicates phenotypically diverse population of Mycobacterium tuberculosis

Arnab Roy, Shashikanta Sau, Puja Kumari Agnivesh, Kishan Kumar Parida, Nitin Pal Kalia

10.1016/j.biopha.2026.119984
View Publication

Redox–mitochondrial–epigenetic network disruption and its intergenerational impact in zebrafish: Protective effects of metformin

Sandeep R. Reddy, Prabhakar Kamarthy, Manjunatha Bangeppagari

10.1016/j.biopha.2026.119979
View Publication

Pharmacokinetics and immunomodulatory effects of selective orexin 1 receptor agonist OXA 17–33: PBMC responses, HPA axis activation, and outcomes in the collagen-induced arthritis model

Daniel Stránský, Monika Šteigerová, Petr Kozlík, Tomáš Křížek, Michaela Sklenárová, Viktória Paulusová, Pavel Ryšánek, Helena Kupcová Skalníková, Sara Merdita, Anežka Klouček, Olesia Symkanych, Jan Hlaváč, Zdeňka Doubková, Martin Šíma, Ondřej Slanař

10.1016/j.biopha.2026.119980
View Publication

Frequently asked questions

How long does it take to publish?

2 days from submission to first decision; 40 days from submission to decision after review; 77 days from submission to acceptance; 6 days from acceptance to online publication.

Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

Is a cover letter required?

A cover letter is required with submission. It should be short, ideally less than one page, explain the study's aim and main findings, show fit with the journal's scope, emphasize novelty and broader implications, and acknowledge any invitation to submit. It should not include funding information, author declarations, or suggested or opposed reviewers.

Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

What are the publication costs?

Article Publishing Charge: USD 3610 excluding taxes for all articles.

Reformat to Biomedicine & Pharmacotherapy using Livewrite Premium

Research Topics

Cancer-related molecular mechanisms research MicroRNA in disease regulation Circular RNAs in diseases RNA modifications and cancer Autophagy in Disease and Therapy Liver Disease Diagnosis and Treatment Cancer, Hypoxia, and Metabolism Genomics, phytochemicals, and oxidative stress Pharmacological Effects of Natural Compounds Natural Antidiabetic Agents Studies Natural product bioactivities and synthesis Neuroinflammation and Neurodegeneration Mechanisms Gut microbiota and health Immune Cell Function and Interaction RNA Interference and Gene Delivery Drug Transport and Resistance Mechanisms Immune cells in cancer Immunotherapy and Immune Responses Epigenetics and DNA Methylation Drug-Induced Hepatotoxicity and Protection Nanoparticle-Based Drug Delivery Phytochemicals and Antioxidant Activities Traditional Chinese Medicine Analysis Tryptophan and brain disorders Immune Response and Inflammation

Related Journals

TI
Trends in Cognitive Sciences Elsevier BV
Bi
Biomaterials Elsevier BV
ND
Neuromuscular Disorders Elsevier BV
RI
Respiratory Investigation Elsevier BV
IJ
International Journal of Cardiology Elsevier BV
TI
Trends in Genetics Elsevier BV